Related Experiment Video
Updated: Jan 8, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association between vascular aging and cardiovascular-kidney-metabolic syndrome
Shuyi Zeng1, Henghua Cui1, Wang Liao1
1Department of Cardiology, The First People's Hospital of Yulin, the Sixth Affiliated Hospital of Guangxi Medical University, Yulin, China.
Insights
Elevated estimated pulse wave velocity (ePWV) is linked to higher Cardiovascular-Kidney-Metabolic syndrome (CKM) risk, especially in young adults. This highlights ePWV as a key marker for CKM progression and cardiovascular disease risk.
Area of Science:
- Cardiology
- Nephrology
- Metabolic Diseases
Background:
- Cardiovascular-Kidney-Metabolic syndrome (CKM) involves complex interactions between metabolic factors, chronic kidney disease (CKD), and cardiovascular health.
- CKM increases susceptibility to organ dysfunction and adverse cardiovascular events.
- Reliable markers are crucial for effective CKM management.
Purpose of the Study:
- To investigate the association between estimated pulse wave velocity (ePWV) and mortality and prognosis in patients with CKM.
- To assess ePWV as a potential biomarker for CKM progression and cardiovascular risk.
Main Methods:
- Analysis of 14,372 participants from the National Health and Nutrition Examination Survey (NHANES) (2005-2018).
- Utilized weighted logistic regression and Cox proportional hazards models to examine the relationship between ePWV and CKM risk.
- Employed bootstrap sampling for mediation analysis of the Triglyceride-Glucose (TyG) index and external validation using a separate cohort.
Main Results:
- A nonlinear positive association was found between ePWV and CKM (P < 0.01), most pronounced in young adults (20-40 years).
- Higher ePWV was significantly associated with worse survival rates.
- The TyG index mediated 25.23% of the ePWV-CKM association; an ePWV threshold of 8.52 for CKM Stage 4 was validated.
Conclusions:
- Elevated ePWV is nonlinearly associated with increased CKM risk, particularly in younger populations.
- ePWV serves as a valuable indicator for arterial stiffness and CKM progression.
- Findings offer insights for managing arterial stiffness and preventing early cardiovascular disease in high-risk individuals.
Background:
The concept of Cardiovascular-Kidney-Metabolic syndrome (CKM), an intricate interplay among metabolic risk factors, chronic kidney disease (CKD), and the cardiovascular system, was introduced by the American Heart Association (AHA). This indicates a markedly increased susceptibility to various organ dysfunctions and adverse cardiovascular events. In CKM management, reliable markers are critical. The purpose of this study was to investigate the relationship between ePWV and mortality and prognosis in patients with CKM.
Methods:
This study included 14,372 participants from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018. ePWV assessed vascular aging and arterial stiffness. The association between ePWV and CKM, as well as their risk of death, was analyzed using weighted logistic regression and Cox proportional hazards models. Bootstrap sampling was used to analyze the mediating effect of the Triglyceride-Glucose Index (TyG) between ePWV and CKM. The Stage 4 ePWV threshold was further validated using an independent retrospective cohort of 3,157 patients from the cardiology department of a tertiary hospital in southern China.
Results:
The RCS analysis demonstrated a nonlinear positive association between estimated pulse wave velocity (ePWV) and cardiovascular-kidney-metabolic syndrome (CKM) (P < 0.01). Subgroup analysis indicated that this association was strongest among young adults aged 20-40 years (P < 0.01), whereas no significant association was observed in elderly individuals over 75 years old (P = 0.791). Kaplan-Meier curves showed that individuals with higher ePWV had significantly worse survival than those with lower ePWV. Further mediation analysis revealed that the triglyceride-glucose (TyG) index mediated 25.23% of the association between ePWV and CKM. In the external validation cohort, the ePWV threshold corresponding to CKM Stage 4 was 8.52, which was consistent in direction and statistical significance with the NHANES-derived model.
Conclusion:
Elevated ePWV is nonlinearly associated with increased CKM risk, particularly among young adults. This finding provides insights into managing arterial stiffness and preventing CKM progression in individuals at high risk of early cardiovascular disease.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Hypertension II: Pathophysiology
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Hypertension and Regulation of Blood Pressure

